Should soluble CD40 ligand be measured from serum or plasma samples? [2] (multiple letters)

Dániel Bereczki; Emõke Nagy; András Pál; Mária T. Magyar; József Balla; Gavin J. Blake; Robert J. Ostfeld; E. Kent Yucel; Nerea Varo; Uwe Schonbeck; Michael A. Blake; Marie Gerhard; Paul M. Ridker; Peter Libby; Richard T. Lee

doi:10.1161/01.ATV.0000072368.37740.8E

Should soluble CD40 ligand be measured from serum or plasma samples? [2] (multiple letters)

Dániel Bereczki, Emõke Nagy, András Pál, Mária T. Magyar, József Balla, Gavin J. Blake, Robert J. Ostfeld, E. Kent Yucel, Nerea Varo, Uwe Schonbeck, Michael A. Blake, Marie Gerhard, Paul M. Ridker, Peter Libby, Richard T. Lee

Research output: Contribution to journal › Letter › peer-review

29 Scopus citations

Original language	English (US)
Pages (from-to)	1129-1131
Number of pages	3
Journal	Arteriosclerosis, thrombosis, and vascular biology
Volume	23
Issue number	6
DOIs	https://doi.org/10.1161/01.ATV.0000072368.37740.8E
State	Published - Jun 1 2003
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1161/01.ATV.0000072368.37740.8E

Cite this

Bereczki, D., Nagy, E., Pál, A., Magyar, M. T., Balla, J., Blake, G. J., Ostfeld, R. J., Yucel, E. K., Varo, N., Schonbeck, U., Blake, M. A., Gerhard, M., Ridker, P. M., Libby, P., & Lee, R. T. (2003). Should soluble CD40 ligand be measured from serum or plasma samples? [2] (multiple letters). Arteriosclerosis, thrombosis, and vascular biology, 23(6), 1129-1131. https://doi.org/10.1161/01.ATV.0000072368.37740.8E

Bereczki, D, Nagy, E, Pál, A, Magyar, MT, Balla, J, Blake, GJ, Ostfeld, RJ, Yucel, EK, Varo, N, Schonbeck, U, Blake, MA, Gerhard, M, Ridker, PM, Libby, P & Lee, RT 2003, 'Should soluble CD40 ligand be measured from serum or plasma samples? [2] (multiple letters)', Arteriosclerosis, thrombosis, and vascular biology, vol. 23, no. 6, pp. 1129-1131. https://doi.org/10.1161/01.ATV.0000072368.37740.8E

@article{d41a4972bd6048f9adbda39f784524d7,

title = "Should soluble CD40 ligand be measured from serum or plasma samples? [2] (multiple letters)",

author = "D{\'a}niel Bereczki and Em{\~o}ke Nagy and Andr{\'a}s P{\'a}l and Magyar, {M{\'a}ria T.} and J{\'o}zsef Balla and Blake, {Gavin J.} and Ostfeld, {Robert J.} and Yucel, {E. Kent} and Nerea Varo and Uwe Schonbeck and Blake, {Michael A.} and Marie Gerhard and Ridker, {Paul M.} and Peter Libby and Lee, {Richard T.}",

year = "2003",

month = jun,

day = "1",

doi = "10.1161/01.ATV.0000072368.37740.8E",

language = "English (US)",

volume = "23",

pages = "1129--1131",

journal = "Arteriosclerosis, thrombosis, and vascular biology",

issn = "1079-5642",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Should soluble CD40 ligand be measured from serum or plasma samples? [2] (multiple letters)

AU - Bereczki, Dániel

AU - Nagy, Emõke

AU - Pál, András

AU - Magyar, Mária T.

AU - Balla, József

AU - Blake, Gavin J.

AU - Ostfeld, Robert J.

AU - Yucel, E. Kent

AU - Varo, Nerea

AU - Schonbeck, Uwe

AU - Blake, Michael A.

AU - Gerhard, Marie

AU - Ridker, Paul M.

AU - Libby, Peter

AU - Lee, Richard T.

PY - 2003/6/1

Y1 - 2003/6/1

UR - http://www.scopus.com/inward/record.url?scp=12444253906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12444253906&partnerID=8YFLogxK

U2 - 10.1161/01.ATV.0000072368.37740.8E

DO - 10.1161/01.ATV.0000072368.37740.8E

M3 - Letter

C2 - 12807715

AN - SCOPUS:12444253906

SN - 1079-5642

VL - 23

SP - 1129

EP - 1131

JO - Arteriosclerosis, thrombosis, and vascular biology

JF - Arteriosclerosis, thrombosis, and vascular biology

IS - 6

ER -

Should soluble CD40 ligand be measured from serum or plasma samples? [2] (multiple letters)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this